To evaluate whether or not the studies of the late/chronic EAE have implications for human MS, we examined Eomes expression by CD4+ T cells in peripheral blood mononuclear cells (PBMCs) derived from healthy controls (HCs), or patients with either RRMS or SPMS. This evidence concerns the gene EOMES and myeloid sarcoma.